1. Home
  2. NVRO vs OPP Comparison

NVRO vs OPP Comparison

Compare NVRO & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVRO
  • OPP
  • Stock Information
  • Founded
  • NVRO 2006
  • OPP 2010
  • Country
  • NVRO United States
  • OPP United States
  • Employees
  • NVRO N/A
  • OPP N/A
  • Industry
  • NVRO Medical/Dental Instruments
  • OPP Finance/Investors Services
  • Sector
  • NVRO Health Care
  • OPP Finance
  • Exchange
  • NVRO Nasdaq
  • OPP Nasdaq
  • Market Cap
  • NVRO 221.2M
  • OPP 204.1M
  • IPO Year
  • NVRO 2014
  • OPP N/A
  • Fundamental
  • Price
  • NVRO $5.84
  • OPP $8.58
  • Analyst Decision
  • NVRO Hold
  • OPP
  • Analyst Count
  • NVRO 12
  • OPP 0
  • Target Price
  • NVRO $7.24
  • OPP N/A
  • AVG Volume (30 Days)
  • NVRO 1.2M
  • OPP 108.0K
  • Earning Date
  • NVRO 05-06-2025
  • OPP 01-01-0001
  • Dividend Yield
  • NVRO N/A
  • OPP 14.41%
  • EPS Growth
  • NVRO N/A
  • OPP N/A
  • EPS
  • NVRO N/A
  • OPP N/A
  • Revenue
  • NVRO $408,518,000.00
  • OPP N/A
  • Revenue This Year
  • NVRO $1.54
  • OPP N/A
  • Revenue Next Year
  • NVRO $4.37
  • OPP N/A
  • P/E Ratio
  • NVRO N/A
  • OPP N/A
  • Revenue Growth
  • NVRO N/A
  • OPP N/A
  • 52 Week Low
  • NVRO $3.17
  • OPP $7.26
  • 52 Week High
  • NVRO $13.84
  • OPP $8.83
  • Technical
  • Relative Strength Index (RSI)
  • NVRO 69.92
  • OPP 46.92
  • Support Level
  • NVRO $5.83
  • OPP $8.55
  • Resistance Level
  • NVRO $5.81
  • OPP $8.71
  • Average True Range (ATR)
  • NVRO 0.02
  • OPP 0.09
  • MACD
  • NVRO -0.02
  • OPP -0.00
  • Stochastic Oscillator
  • NVRO 81.82
  • OPP 33.33

About NVRO Nevro Corp.

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.

Share on Social Networks: